Innovative Strategies in Heart Failure: Present and Future

Area of Science:

• Cardiology
• Medical Therapy

Background:

• Heart failure (HF) significantly reduces life expectancy and quality of life, particularly in older adults.
• HF remains a leading cause of hospitalization for individuals over 65, with incidence rates unchanged in two decades.
• While survival has improved for younger patients and men, HF continues to pose a substantial healthcare burden.

Purpose of the Study:

• To review the historical evolution of heart failure management strategies.
• To discuss current therapeutic discoveries in heart failure treatment.
• To provide insights into emerging and future therapies, including regenerative medicine.

Main Methods:

• Historical review of heart failure treatment eras.
• Analysis of therapeutic advancements in pharmacologic and device-based interventions.
• Exploration of novel regenerative therapies for heart failure.

Main Results:

• HF management has progressed through non-pharmacologic, pharmacologic, and device-based eras.
• Significant advancements have been made in medications targeting neurohormonal pathways and in implantable devices.
• Regenerative therapies represent a potential fourth era in heart failure treatment.

Conclusions:

• Heart failure treatment has evolved significantly over 50 years.
• Current therapies have improved survival but HF remains a major health challenge.
• Regenerative medicine holds promise for future breakthroughs in heart failure management.